Objectives: We examined levels of the urinary polycyclic aromatic hydrocarbon (PAH) biomarker r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (PheT) in smokers who switched to either snus or nicotine gum. We also examined differences in PheT levels as a function of whether smokers used both their assigned product (eg, snus or nicotine gum) and cigarettes, or switched completely to
... [Show full abstract] product. Methods: Cigarette smokers (N = 308, 46.4% women) were randomized to receive snus or nicotine gum and were instructed to use only their assigned product for 12 weeks. Urine samples for analysis of PheT were collected at baseline and 4 weeks after receiving product. Results: All participants showed reductions in PheT regardless of product and whether they continued smoking while using product (p < .003); however, reductions were greater among those who completely switched to nicotine gum or snus. No differences emerged between smokers provided with nicotine gum versus snus in PheT levels after 4 weeks of use (p > .05). Conclusions: Switching to snus or nicotine gum appears to result in similar reductions in smokers' levels of urinary PheT with the greatest reductions among those who avoid smoking completely.